Trials / Recruiting
RecruitingNCT05159544
The FuSion Program: A Prospective and Multicenter Cohort Study of Pan-Cancer Screening in Chinese Population
A Prospective, Multicenter, Noninterventional Cohort Study of Muti-Omics Models for Pan-Cancer Screening
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 60,000 (estimated)
- Sponsor
- Singlera Genomics Inc. · Industry
- Sex
- All
- Age
- 40 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
The integrative study by Fudan and Singlera for cancer early detection(The FuSion Program ) will evaluate sensitivity,specificity and positive/negative predictive value of the screening model jointly developed by FuDan University and Singlera in a 2-year follow-up corhort including 10,000 persons in routine annual physicals from dozens of hospitals. The multi-omics model for pan-cancer screening will be developed in a 3-year follow-up corhort including 50,000 natural persons in community containing genetic information of tumor families, assessment of epidemiological risk factors, tumor markers, proteomics, genomics and DNA methylation. After optimizing, the ability of this model will be validated in the Taizhou corhort in reality.
Conditions
Timeline
- Start date
- 2021-07-06
- Primary completion
- 2024-07-06
- Completion
- 2024-12-07
- First posted
- 2021-12-16
- Last updated
- 2024-04-17
Locations
12 sites across 1 country: China
Source: ClinicalTrials.gov record NCT05159544. Inclusion in this directory is not an endorsement.